<div class="table-wrap table anchored whole_rhythm" id="T2">
<h3>Table 2</h3>
<!--caption a7--><div class="caption"><p id="__p26">Baseline
 demographics, disease characteristics and prior and concomitant 
therapies of patients who had an insufficient response to methotrexate</p></div>
<div data-largeobj="" data-largeobj-link-rid="largeobj_idm140576997103680" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table">
<thead>
<tr>
<td rowspan="2" colspan="1" valign="bottom" align="left">Characteristic</td>
<td colspan="2" rowspan="1" valign="bottom" align="left">Patients with an insufficient response to methotrexate at 6 months (n=525)<sup><a href="#tblfn6" rid="tblfn6" class=" fn">*</a></sup>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="bottom" align="left">OPTIMA <br>Adalimumab <br>Rescue (n=348)</td>
<td rowspan="1" colspan="1" valign="bottom" align="left">PREMIER <br>Methotrexate <br>Monotherapy (n=177)</td>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left">Demographic characteristics</td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> Women, n (%)</td>
<td rowspan="1" colspan="1" valign="top" align="center">266 (76)</td>
<td rowspan="1" colspan="1" valign="top" align="center">132 (75)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> White, n (%)</td>
<td rowspan="1" colspan="1" valign="top" align="center">313 (90)</td>
<td rowspan="1" colspan="1" valign="top" align="center">170 (96)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> Age (years)</td>
<td rowspan="1" colspan="1" valign="top" align="center">50.7 (13.9)</td>
<td rowspan="1" colspan="1" valign="top" align="center">52.5 (13.3)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> RA duration (years)</td>
<td rowspan="1" colspan="1" valign="top" align="center">0.3 (0.3)</td>
<td rowspan="1" colspan="1" valign="top" align="center">0.8 (0.9)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> Weight (kg)</td>
<td rowspan="1" colspan="1" valign="top" align="center">77.5 (20.8)</td>
<td rowspan="1" colspan="1" valign="top" align="center">76.5 (18.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> BMI (kg/m<sup>2</sup>)</td>
<td rowspan="1" colspan="1" valign="top" align="center">28.4 (6.8)†</td>
<td rowspan="1" colspan="1" valign="top" align="center">27.6 (6.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left">Disease characteristics</td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> RF+, n (%)</td>
<td rowspan="1" colspan="1" valign="top" align="left">302 (88)‡</td>
<td rowspan="1" colspan="1" valign="top" align="center">147 (83)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> CRP (mg/L)</td>
<td rowspan="1" colspan="1" valign="top" align="center">32.6 (33.3)</td>
<td rowspan="1" colspan="1" valign="top" align="center">41.8 (41.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> TJC68</td>
<td rowspan="1" colspan="1" valign="top" align="center">28.6 (14.7)</td>
<td rowspan="1" colspan="1" valign="top" align="center">33.3 (14.7)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> SJC66</td>
<td rowspan="1" colspan="1" valign="top" align="center">19.1 (10.7)</td>
<td rowspan="1" colspan="1" valign="top" align="center">22.9 (12.3)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> DAS28(CRP)</td>
<td rowspan="1" colspan="1" valign="top" align="center">6.1 (0.9)§</td>
<td rowspan="1" colspan="1" valign="top" align="center">6.4 (0.8)¶</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> SDAI</td>
<td rowspan="1" colspan="1" valign="top" align="center">45.2 (13.7)§</td>
<td rowspan="1" colspan="1" valign="top" align="center">49.7 (13.5)**</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> HAQ-DI (range, 0–3)</td>
<td rowspan="1" colspan="1" valign="top" align="center">1.7 (0.6)†</td>
<td rowspan="1" colspan="1" valign="top" align="center">1.5 (0.7)¶</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> mTSS</td>
<td rowspan="1" colspan="1" valign="top" align="center">11.7 (18.5)†</td>
<td rowspan="1" colspan="1" valign="top" align="center">23.0 (22.5)**</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> &gt;1 erosion, n (%)</td>
<td rowspan="1" colspan="1" valign="top" align="left">217 (63)†</td>
<td rowspan="1" colspan="1" valign="top" align="center">155 (89)**</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left">Prior therapies</td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> Systemic glucocorticoids, n (%)</td>
<td rowspan="1" colspan="1" valign="top" align="center">133 (38)</td>
<td rowspan="1" colspan="1" valign="top" align="center">83 (47)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> ≥1 DMARD, n (%)</td>
<td rowspan="1" colspan="1" valign="top" align="center">34 (10)</td>
<td rowspan="1" colspan="1" valign="top" align="center">54 (31)</td>
</tr>
</tbody>
</table></div>
<div id="largeobj_idm140576997103680" class="largeobj-link align_right" style="display: none"><a target="object" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225797/table/T2/?report=objectonly">Open in a separate window</a></div>
<div class="tblwrap-foot">
<div id="tblfn5"><p id="__p27" class="p p-first-last">Values are mean (SD), unless otherwise indicated.</p></div>
<div id="tblfn6"><p id="__p28" class="p p-first-last">*n
 consists of patients treated with placebo+methotrexate who did not 
achieve DAS28(CRP) &lt;3.2 at week 24/26 for OPTIMA or 
week 20/24 for PREMIER.</p></div>
<div id="tblfn7"><p id="__p29" class="p p-first-last">†n=347 non-missing values.</p></div>
<div id="tblfn8"><p id="__p30" class="p p-first-last">‡n=344 non-missing values.</p></div>
<div id="tblfn9"><p id="__p31" class="p p-first-last">§n=341 non-missing values.</p></div>
<div id="tblfn10"><p id="__p32" class="p p-first-last">¶n=176 non-missing values.</p></div>
<div id="tblfn11"><p id="__p33" class="p p-first-last">**n=174 non-missing values.</p></div>
<div id="tblfn12"><p id="__p34" class="p p-first-last">BMI,
 body mass index; CRP, C-reactive protein; DAS28(CRP), 28-joint Disease 
Activity Score based on CRP; DMARD, disease-modifying antirheumatic 
drug; HAQ-DI, Health Assessment Questionnaire Disability Index; mTSS, 
modified total Sharp score; NA, not available; OPTIMA, Optimal 
Protocol for Treatment Initiation with Methotrexate and 
Adalimumab; RA, rheumatoid arthritis; RF, rheumatoid factor; SDAI, 
Simplified Disease Activity Index; SJC66, swollen joint count based on 
66 joints; TJC68, tender joint count based on 68 joints.</p></div>
</div>
</div>